ReviewJournal of the advanced practitioner in oncology2016

Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma.

Katelyn Hood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.